{"id":"W2601739689","doi":"10.1016/j.diabet.2017.01.004","title":"Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial","year":2017,"lang":"en","type":"article","venue":"Diabetes & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Internal medicine; Type 2 diabetes; Placebo; PCSK9; Insulin; Statin; Diabetes mellitus; Endocrinology; Randomized controlled trial; Gastroenterology; Cholesterol; Lipoprotein; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001008832,0.0002150487,0.001011655,0.00008883779,0.0001821449,0.0000296289,0.0001219133,0.0001273988,0.00001116927],"category_scores_gemma":[0.001046053,0.000124578,0.000108102,0.0002063175,0.000272952,0.0001208936,0.0001077828,0.0001847781,7.232942e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001493508,"about_ca_system_score_gemma":0.0001285592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00029811,"about_ca_topic_score_gemma":0.00001256879,"domain_scores_codex":[0.9981921,0.0003494121,0.0003943745,0.000340589,0.0004734193,0.0002501138],"domain_scores_gemma":[0.9983194,0.0001583196,0.0002884866,0.0008296915,0.0002928889,0.0001111632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03105838,0.00076444,0.8053076,0.0007321406,0.004827814,0.000006195014,0.000914819,0.0001723863,0.00122943,0.0001326624,0.00005119431,0.154803],"study_design_scores_gemma":[0.05347247,0.0005869045,0.9411069,0.0001844349,0.001121707,6.337566e-7,0.00001594604,0.00009182636,0.002310032,0.00005114778,0.0009157975,0.000142203],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787579,0.01873606,0.00001127771,0.00004451628,0.0001623612,0.002211436,0.00004871199,0.000009214992,0.00001858158],"genre_scores_gemma":[0.9954097,0.003710854,0.0006054621,0.00003417547,0.0001298857,0.00003278466,0.00002729005,0.00002704407,0.00002280692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1546608,"threshold_uncertainty_score":0.5080142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01402660249485692,"score_gpt":0.230289866264427,"score_spread":0.2162632637695701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}